BIRC2
Baculoviral IAP repeat-containing protein 2
Also known as: API1, BIRC2_HUMAN, c-IAP1, cIAP1, hiap-2, MIHB, RNF48
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13490
- Gene
- BIRC2
- Ensembl
- ENSG00000110330
- Chromosome
- 11
- Canonical length
- 618 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of a family of proteins that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. This encoded protein inhibits apoptosis induced by serum deprivation and menadione, a potent inducer of free radicals. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
618 residues, UniProt reviewed canonical sequence.
>Q13490|BIRC2
1 MHKTASQRLF PGPSYQNIKS IMEDSTILSD WTNSNKQKMK YDFSCELYRM STYSTFPAGV
61 PVSERSLARA GFYYTGVNDK VKCFCCGLML DNWKLGDSPI QKHKQLYPSC SFIQNLVSAS
121 LGSTSKNTSP MRNSFAHSLS PTLEHSSLFS GSYSSLSPNP LNSRAVEDIS SSRTNPYSYA
181 MSTEEARFLT YHMWPLTFLS PSELARAGFY YIGPGDRVAC FACGGKLSNW EPKDDAMSEH
241 RRHFPNCPFL ENSLETLRFS ISNLSMQTHA ARMRTFMYWP SSVPVQPEQL ASAGFYYVGR
301 NDDVKCFCCD GGLRCWESGD DPWVEHAKWF PRCEFLIRMK GQEFVDEIQG RYPHLLEQLL
361 STSDTTGEEN ADPPIIHFGP GESSSEDAVM MNTPVVKSAL EMGFNRDLVK QTVQSKILTT
421 GENYKTVNDI VSALLNAEDE KREEEKEKQA EEMASDDLSL IRKNRMALFQ QLTCVLPILD
481 NLLKANVINK QEHDIIKQKT QIPLQARELI DTILVKGNAA ANIFKNCLKE IDSTLYKNLF
541 VDKNMKYIPT EDVSGLSLEE QLRRLQEERT CKVCMDKEVS VVFIPCGHLV VCQECAPSLR
601 KCPICRGIIK GTVRTFLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BIRC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- thymus: 47 nTPM
- liver: 41 nTPM
- bone marrow: 34 nTPM
- lymph node: 32 nTPM
- pancreas: 32 nTPM
- tongue: 31 nTPM
Single-cell type
- neutrophils: 242 nCPM
- hepatocytes: 218 nCPM
- epididymal basal cells: 193 nCPM
- epididymal principal cells: 155 nCPM
- monocytes: 145 nCPM
- endometrial luminal cells: 121 nCPM
Immune cell
- eosinophil: 102 nTPM
- basophil: 93 nTPM
- neutrophil: 67 nTPM
- non-classical monocyte: 44 nTPM
- classical monocyte: 42 nTPM
- intermediate monocyte: 40 nTPM
Brain region
- white matter: 32 nTPM
- choroid plexus: 28 nTPM
- midbrain: 23 nTPM
- medulla oblongata: 23 nTPM
- hypothalamus: 23 nTPM
- spinal cord: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BIRC2.
Disease | ImmuneIEDB
Conditions an epitope on BIRC2 was assayed in.
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.43
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- canonical NF-kappaB signal transduction
- cell surface receptor signaling pathway
- necroptotic process
- negative regulation of apoptotic process
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of necroptotic process
- non-canonical NF-kappaB signal transduction
- placenta development
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of protein K48-linked ubiquitination
- positive regulation of protein K63-linked ubiquitination
- positive regulation of protein monoubiquitination
- positive regulation of protein ubiquitination
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein polyubiquitination
- regulation of apoptotic process
- regulation of cell cycle
- regulation of cell differentiation
- regulation of cell population proliferation
- regulation of inflammatory response
- regulation of innate immune response
- regulation of necroptotic process
- regulation of non-canonical NF-kappaB signal transduction
- regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
- regulation of reactive oxygen species metabolic process
- regulation of RIG-I signaling pathway
- regulation of toll-like receptor signaling pathway
- response to bleomycin
- response to cAMP
- response to ethanol
- response to hypoxia
- tumor necrosis factor-mediated signaling pathway
- negative regulation of ripoptosome assembly involved in necroptotic process
Molecular functions
- cysteine-type endopeptidase inhibitor activity involved in apoptotic process
- FBXO family protein binding
- identical protein binding
- protein-containing complex binding
- protein-folding chaperone binding
- transcription coactivator activity
- transferase activity
- ubiquitin binding
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BIRC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BIRC2 as an antibody target. Whether an autoantibody or antibody against BIRC2 could matter depends on whether native BIRC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BIRC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BIRC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...